NCT05402696 St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
| NCT ID | NCT05402696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Colon Adenoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,500 participants |
| Start Date | 2022-06-27 |
| Primary Completion | 2032-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,500 participants in total. It began in 2022-06-27 with a primary completion date of 2032-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The SPARC-C study is a prospective, multi-institutional observational study of patients referred for the management of large (≥ 20mm) non-pedunculated colorectal polyps (LNPCPs). Patients are managed consistent with current standards of care. Prospectively collected data includes: patient clinicodemographic details, lesion details, procedural details, and clinical outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients ≥ 18 years of age referred for the management of an LNPCP * Able to provide informed consent. Exclusion Criteria: * Unable to provide informed consent * Pregnant or lactating women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05402696 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colon Adenoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05402696 currently recruiting?
Yes, NCT05402696 is actively recruiting participants. Contact the research team at sjiangx@alumni.ubc.ca for enrollment information.
Where is the NCT05402696 trial being conducted?
This trial is being conducted at Saint Cloud, United States, Vancouver, Canada, Vancouver, Canada, Vancouver, Canada and 2 additional locations.
Who is sponsoring the NCT05402696 clinical trial?
NCT05402696 is sponsored by University of British Columbia. The trial plans to enroll 3,500 participants.